International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCasanova, Michela
dc.contributor.authorOzyar, Enis
dc.contributor.authorPatte, Catherine
dc.contributor.authorOrbach, Daniel
dc.contributor.authorFerrari, Andrea
dc.contributor.authorVeyrat\\-Follet, Christine
dc.contributor.authorErrihani, Hassan
dc.contributor.authorPan, Jianji
dc.contributor.authorZhang, Li
dc.contributor.authorShen, Liji
dc.contributor.authorGrzegorzewski, Krzysztof J.
dc.contributor.authorVaran, Ali
dc.date.accessioned2025-10-16T15:29:34Z
dc.date.issued2016
dc.identifier.doi10.1007/s00280-015-2933-2
dc.identifier.otherWOS:000370155300008
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8800
dc.publisherSPRINGER
dc.sourceCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.subjectPediatric nasopharyngeal carcinoma
dc.subjectCisplatin
dc.subjectDocetaxel
dc.subject5\\-Fluorouracil
dc.subjectPharmacokinetics
dc.titleInternational randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS